Purchase Order HHSN272201501092P
Award Date
8/18/15
Potential Completion Date
12/31/15
Potential Value
$23K
Federal Agency
NIAID DEA OA Acquisitions
Awardee
Stemcell Technologies Inc.
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,616.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the provision of EasySep Negative Human CD4 Kits, which are specialized cell separation products used to support biomedical research initiatives, particularly in the areas of stem cell research, immunology, cancer...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, valued at $5,636.00, is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research. Stemcell Technologies Inc....
This $9,759 federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the provision of "Negative Human CD4 Kits", which are likely specialized biological materials and cell isolation kits to support biomedical research on infectious diseases....
This is a federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of an EasySep Negative Human CD4 Kit, catalog number 19052. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $39,906.40 and is structured as a firm fixed price purchase order. The contract is...
This federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS). The $24,536.00 firm fixed-price purchase order is for the provision of the AMBIS 1787964 QUOTE Q-921198 item, which is described as the "EASY STEP NEGATIVE HUMAN CD4 KIT". The award does not have a small business set-aside designation. Stemcell...
This federal contract award was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research products. The contract, which is a Blanket Purchase Agreement (BPA) with a ceiling value of $10,000,000, authorizes Stemcell Technologies Inc. to provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $12,670.00 firm fixed price purchase order to Stemcell Technologies Inc., a Canadian-owned for-profit company, for CD4 EASYSEP NEGATIVE SELECTION KITS. This award was not set aside for any particular business type. Stemcell Technologies Inc. is an experienced federal contractor that frequently provides specialized biological materials, lab supplies, scientific...
This federal contract award, valued at $11,170.80, was issued by the National Institute of Allergy and Infectious Diseases (NIAID) to Stemcell Technologies Inc., a Canadian biotechnology company. The contract, which is not set aside for small businesses, is for the provision of specialized biological materials, laboratory supplies, scientific equipment, and proprietary products to support biomedical research initiatives across various government agencies, particularly within the Department of...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The $28,882 firm-fixed-price contract is for the delivery of EasySep Human Pan-B Cell Enrichment Kits, a product used to isolate B cells for biomedical research. The award is not a set-aside for small businesses. Stemcell Technologies Inc. is the prime contractor and...
The National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS), awarded a $80,536.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc. for EasySep Negative Human CD4 and CD8 Kits. This contract does not have a set-aside designation. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research...